TABLE 2.

Associations between recipient, donor and procedure characteristics and DGF in final multivariable analyses (n = 687).

Recipient/Donor/Procedure characteristics	Univariable odds ratio (95% CI a )	p-value	Multivariable odds ratio (95% CI a )	p-value
Pre-transplant elevated anti-LG3 antibodies b
In cold static storage	1.58 (1.03, 2.39)	0.04	1.75 (1.02, 3.00)	0.04
Placed on a hypothermic perfusion machine	0.65 (0.33, 1.29)	0.22	0.78 (0.44, 1.37)	0.38
Recipient age at transplant (per 10 years higher)	1.17 (1.04, 1.31)	<0.01	0.98 (0.97, 1.00)	0.06
Recipient African American race (versus Caucasian)	1.80 (1.03, 3.14)	0.04	0.84 (0.39, 1.79)	0.65
Time on dialysis pre-transplant (per 1-month higher)	1.00 (1.00, 1.20)	<0.01	1.01 (1.01, 1.02)	<0.01
Recipient diabetes	2.34 (1.63, 3.36)	<0.01	2.14 (1.35, 3.39)	<0.01
Recipient positive CMV serology	1.28 (0.94, 1.74)	0.11	1.02 (0.68, 1.54)	0.92
Recipient ACE inhibitor/angiotensin-2 blocker use at transplantation	0.57 (0.42, 0.79)	<0.01	0.54 (0.37, 0.81)	<0.01
Previous transplantations	1.69 (1.04, 2.74)	0.03	1.61 (0.84, 3.10)	0.15
Thymoglobulin induction	2.34 (1.63, 3.35)	<0.01	2.24 (1.36, 3.69)	<0.01
Donor type (References neurologically deceased)
Living donor	0.12 (0.06, 0.21)	<0.01	0.21 (0.11, 0.41)	<0.01
Donor after cardiac arrest	4.10 (2.37, 7.11)	<0.01	4.99 (2.62, 9.50)	<0.01
Donor age (per 10-year higher)	1.30 (1.17, 1.45)	<0.01	1.48 (1.28, 1.72)	<0.01
Donor height (per 10 cm higher)	0.82 (0.71, 0.95)	<0.01	0.75 (2.34, 15.63)	<0.01
Donor peripheral vascular disease	2.00 (1.18, 3.40)	0.01	0.96 (0.50, 1.87)	0.91
Donor diabetes	1.52 (0.86, 2.69)	0.15	0.94 (0.48, 1.85)	0.59
Donor terminal serum creatinine ≥120 umol/L	4.69 (2.05, 10.69)	<0.01	6.14 (2.37, 15.92)	<0.01
Center 1	0.31 (0.22, 0.42)	<0.01	0.38 (0.23, 0.63)	<0.01
Transplant date (per 1 year higher)	1.04 (0.97, 1.11)	0.26	1.03 (0.93, 1.13)	0.86

^a CI, confidence interval.

^b The p-value for the interaction between anti-LG3 and use of hypothermic pump is 0.02.